UK markets closed

Hyloris Pharmaceuticals SA (52U.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
11.70+0.05 (+0.43%)
As of 08:12AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
3,078
2,951
3,096
175
Cost of revenue
79
94
107
145
Gross profit
2,999
2,857
2,989
30
Operating expenses
Research development
12,310
10,151
5,056
3,413
Selling general and administrative
4,733
3,517
2,900
2,194
Total operating expenses
15,705
13,365
13,337
5,586
Operating income or loss
-12,706
-10,508
-10,348
-5,556
Interest expense
-302
219
556
992
Income before tax
-12,458
-10,766
-11,282
-7,145
Income tax expense
-
4
297
1
Income from continuing operations
-12,462
-10,770
-11,579
-7,146
Net income
-12,462
-10,770
-11,579
-7,145
Net income available to common shareholders
-12,462
-10,770
-11,579
-7,145
Basic EPS
-0.46
-0.40
-0.45
-0.33
Diluted EPS
-0.46
-0.40
-0.45
-0.33
Basic average shares
-
27,199
25,833
21,819
Diluted average shares
-
27,199
25,833
21,819